Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Disorders in Relapsing-Remitting Multiple Sclerosis
NCT01074619Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Sep 2005
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in relapsing-remitting multiple sclerosis (RRMS), sponsored by CHU Caen Normandie. Started Sep 2005; status: completed.
02
Drugs
memantine
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01074619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074619.